Skip to main content

Table 4 Administration setting (%) for biologic agents

From: Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece

Agent Hospital Pharmacy Dermatologist’s private office Nurse at home Alone at home Health center/private clinic
Adalimumab 9 12 2 8 60 8
Etanercept 11 12 4 9 58 7
Infliximab 99 0 1 0 0 0
Ustekinumab 68 3 2 16 12 0
  1. Note: The percentages do not sum up to 100% across all rows because of rounding.